Please see below for a selection of interesting articles on pediatric CML in peer-reviewed journals. Latest publications include:

• Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia
  (Hijiya N et al. Blood, September 2019) (epub ahead of print)
• Pediatric chronic myeloid leukemia presenting in a mixed phenotypic blast crisis: A rare occurrence
  (Bhattacharya J et al. Turk H Haematol, August 2019)
• The small problem when treating childhood chronic myeloid leukemia
  (Suttorp M et al. Pediatr Hematol Oncol, July 2019) (epub ahead of print)
• Effect of imatinib on growth in children with chronic myeloid leukemia
  (Boddu D et al. Pediatr Hematol Oncol, July 2019) (epub ahead of print)
• Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia
  (Liu Y et al. AMB Express, July 2019)

Search here for more publications on pediatric CML